Affirma Biotech
PrivateLast Round
VC Round
Feb 1, 2024
Total Funding Raised
$1.31M
Company Overview
Affirma Biotech operates in Healthcare & Life Sciences and is based in Barcelona. Its latest recorded funding round was a VC Round in February 2024.
Affirma Biotech is a biotechnology company that develops orally available immunotherapeutic drugs for the treatment of severe infections and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Affirma Biotech Comparables
Compare Affirma Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aligos Therapeutics | 74% | |
| Olgram | 74% | |
| Arbutus Biopharma Corp | 74% |
For institutional investors. Book with your work email.
Affirma Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 1, 2024 | ||||
| Grant | Nov 21, 2023 | ||||
| Seed | Sep 19, 2022 | ||||
| Pre Seed | Dec 10, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Affirma Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nara Capital | VC Round |
| SeedBlink | VC Round |
| Center for Technological Development and Innovation | Grant |
| Capital Cell | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2026
Monthly visitors increased 81% MoM.
- May 1, 2025
Monthly visitors grew 71% MoM, from 762 to 1.3K.
For institutional investors. Book with your work email.
Affirma Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Affirma Biotech's valuation, stock price, and market status.
Is Affirma Biotech a public or private company?
Affirma Biotech is a private company.
What is the current stock price of Affirma Biotech?
Affirma Biotech is a private company, so its shares have no public market price. Caplight tracks Affirma Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Affirma Biotech worth (valuation)?
Valuation information for Affirma Biotech is not publicly available.
Can I buy Affirma Biotech stock?
Affirma Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Affirma Biotech's last funding round?
Affirma Biotech's most recent funding round was VC Round on February 1, 2024.
Who are the main investors in Affirma Biotech?
Key investors in Affirma Biotech include Nara Capital.
Will Affirma Biotech IPO soon?
No public IPO plans have been announced for Affirma Biotech.
How can I track Affirma Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Affirma Biotech's shares on secondary markets.